TENX logo

TENX
Tenax Therapeutics Inc

16,935
Mkt Cap
$317.77M
Volume
497,605.00
52W High
$18.38
52W Low
$5.34
PE Ratio
-8.56
TENX Fundamentals
Price
$11.88
Prev Close
$11.98
Open
$11.98
50D MA
$13.65
Beta
0.48
Avg. Volume
597,345.06
EPS (Annual)
-$1.34
P/B
2.54
Rev/Employee
$0.00
$380.49
Loading...
Loading...
News
all
press releases
Tenax Therapeutics, Inc. (NASDAQ:TENX) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, four have assigned a buy...
News Placeholder
More News
News Placeholder
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving Average - What's Next...
News Placeholder
Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Tenax Therapeutics, Inc. (NASDAQ:TENX - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, Marketbeat.com reports. One equities...
News Placeholder
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next?
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200-Day Moving Average - What's Next...
News Placeholder
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?
Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above Two Hundred Day Moving Average - Should You Sell...
News Placeholder
Cantor Fitzgerald Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX)
Cantor Fitzgerald began coverage on shares of Tenax Therapeutics in a research report on Tuesday. They set an "overweight" rating and a $35.00 target price on the stock...
News Placeholder
Boothbay Fund Management LLC Purchases Shares of 352,206 Tenax Therapeutics, Inc. $TENX
Boothbay Fund Management LLC acquired a new position in shares of Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) in the third quarter, according to its most recent Form 13F filing with the...
News Placeholder
Tenax Therapeutics (TENX) Expected to Announce Quarterly Earnings on Tuesday
Tenax Therapeutics (NASDAQ:TENX) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 24. (View Earnings Report at...
News Placeholder
Guggenheim Issues Positive Forecast for Tenax Therapeutics (NASDAQ:TENX) Stock Price
Guggenheim raised their price target on shares of Tenax Therapeutics from $25.00 to $34.00 and gave the stock a "buy" rating in a report on Monday...
News Placeholder
What is Lifesci Capital's Forecast for TENX Q1 Earnings?
Tenax Therapeutics, Inc. (NASDAQ:TENX - Free Report) - Equities researchers at Lifesci Capital issued their Q1 2026 earnings estimates for Tenax Therapeutics in a report released on Thursday, March...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available